 |
PDBsum entry 3gcb
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.40
- bleomycin hydrolase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Inactivates bleomycin B2 (a cytotoxic glycometallopeptide) by hydrolysis of a carboxyamide bond of b-aminoalanine, but also shows general aminopeptidase activity. The specificity varies somewhat with source, but amino acid arylamides of Met, Leu and Ala are preferred.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
93:103-109
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
The unusual active site of Gal6/bleomycin hydrolase can act as a carboxypeptidase, aminopeptidase, and peptide ligase.
|
|
W.Zheng,
S.A.Johnston,
L.Joshua-Tor.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Gal6 protease is in a class of cysteine peptidases identified by their
ability to inactivate the anti-cancer drug bleomycin. The protein forms a barrel
structure with the active sites embedded in a channel as in the proteasome. In
Gal6 the C termini lie in the active site clefts. We show that Gal6 acts as a
carboxypeptidase on its C terminus to convert itself to an aminopeptidase and
peptide ligase. The substrate specificity of the peptidase activity is
determined by the position of the C terminus of Gal6 rather than the sequence of
the substrate. We propose a model to explain these diverse activities and Gal6's
singular ability to inactivate bleomycin.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. G450A Has a Different Processing Pattern from the
Wild-Type ProteinAn electrospray mass spectrometry shows G450A
protein cleaving either one or three residues of the C terminus.
|
 |
Figure 6.
Figure 6. Possible Mechanism of Bleomycin Hydrolysis by
Bleomycin Hydrolase
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1998,
93,
103-109)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.R.Berkers,
A.de Jong,
H.Ovaa,
and
B.Rodenko
(2009).
Transpeptidation and reverse proteolysis and their consequences for immunity.
|
| |
Int J Biochem Cell Biol,
41,
66-71.
|
 |
|
|
|
|
 |
H.Jakubowski
(2007).
The molecular basis of homocysteine thiolactone-mediated vascular disease.
|
| |
Clin Chem Lab Med,
45,
1704-1716.
|
 |
|
|
|
|
 |
S.E.Montoya,
E.Thiels,
J.P.Card,
and
J.S.Lazo
(2007).
Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase.
|
| |
Neuroscience,
146,
890-900.
|
 |
|
|
|
|
 |
H.R.Stennicke,
and
G.S.Salvesen
(2006).
Chemical ligation--an unusual paradigm in protease inhibition.
|
| |
Mol Cell,
21,
727-728.
|
 |
|
|
|
|
 |
J.Zimny,
M.Sikora,
A.Guranowski,
and
H.Jakubowski
(2006).
Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
|
| |
J Biol Chem,
281,
22485-22492.
|
 |
|
|
|
|
 |
D.Vivares,
P.Arnoux,
and
D.Pignol
(2005).
A papain-like enzyme at work: native and acyl-enzyme intermediate structures in phytochelatin synthesis.
|
| |
Proc Natl Acad Sci U S A,
102,
18848-18853.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Liu,
B.Lu,
I.Lee,
G.Ondrovicová,
E.Kutejová,
and
C.K.Suzuki
(2004).
DNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrate.
|
| |
J Biol Chem,
279,
13902-13910.
|
 |
|
|
|
|
 |
O.Vasiljeva,
M.Dolinar,
V.Turk,
and
B.Turk
(2003).
Recombinant human cathepsin H lacking the mini chain is an endopeptidase.
|
| |
Biochemistry,
42,
13522-13528.
|
 |
|
|
|
|
 |
H.Wang,
and
D.Ramotar
(2002).
Cellular resistance to bleomycin in Saccharomyces cerevisiae is not affected by changes in bleomycin hydrolase levels.
|
| |
Biochem Cell Biol,
80,
789-796.
|
 |
|
|
|
|
 |
A.Ferdous,
F.Gonzalez,
L.Sun,
T.Kodadek,
and
S.A.Johnston
(2001).
The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II.
|
| |
Mol Cell,
7,
981-991.
|
 |
|
|
|
|
 |
P.A.O'Farrell,
F.Gonzalez,
W.Zheng,
S.A.Johnston,
and
L.Joshua-Tor
(1999).
Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease.
|
| |
Structure,
7,
619-627.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.C.Cheng,
V.Ramakrishnan,
and
S.I.Chan
(1999).
Purification and characterization of a cobalt-activated carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus.
|
| |
Protein Sci,
8,
2474-2486.
|
 |
|
|
|
|
 |
R.S.Bhatnagar,
K.Fütterer,
T.A.Farazi,
S.Korolev,
C.L.Murray,
E.Jackson-Machelski,
G.W.Gokel,
J.I.Gordon,
and
G.Waksman
(1998).
Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs.
|
| |
Nat Struct Biol,
5,
1091-1097.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |